IGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD, PLASMA,AND ORAL FLUID.

DEFINITIVE CONTRACT won by ORASURE TECHNOLOGIES INC · work in BETHLEHEM, PA
$10,607,996
RecipientORASURE TECHNOLOGIES INC UEI Y79RWFLHWDM6
Award IDHHSO100201500009C
Award amount$10,607,996
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PSCAN13
Start dateJun 2, 2015
End dateAug 31, 2022
Place of performanceBETHLEHEM, PA
Record updatedSep 8, 2025

View the official award record

More awards won by ORASURE TECHNOLOGIES INC

8508632127!INTELISWAB COVID-19 ST OTC U
Department of Defense · $388,440,000 · Oct 20, 2021
4610096446!ECAT BRANCH - PHILADELPHIA
Department of Defense · $107,280,000 · Nov 22, 2022
COVID 19 DIB FOR ORASURE TECHNOLOGIES COVID-19 HOME TEST INDUSTRIAL BASE EXPANSION
Department of Health and Human Services · $78,124,049 · Sep 30, 2021
8508548459!ORASURE TEST KIT
Department of Defense · $56,423,400 · Sep 22, 2021
8509606733!INTELISWAB COVID-19 RAPID TE
Department of Defense · $53,640,000 · Dec 22, 2022

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids